to Evaluate the Effect of Food Intake on the Pharmacokinetic of Single Dose SPH3127 Tablets in Chinese Health Subjects

Trial Profile

to Evaluate the Effect of Food Intake on the Pharmacokinetic of Single Dose SPH3127 Tablets in Chinese Health Subjects

Recruiting
Phase of Trial: Phase I

Latest Information Update: 02 Nov 2017

At a glance

  • Drugs SPH 3127 (Primary)
  • Indications Hypertension
  • Focus Pharmacokinetics
  • Sponsors Shanghai Pharmaceuticals Holding
  • Most Recent Events

    • 27 Oct 2017 Status changed from not yet recruiting to recruiting.
    • 17 Aug 2017 Planned End Date changed from 30 Aug 2018 to 30 Sep 2018.
    • 17 Aug 2017 Planned primary completion date changed from 30 Aug 2018 to 30 Sep 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top